Results 101 to 110 of about 110,071 (192)
Background: Many new mRNA-based vaccine candidates in liquid mRNA-LNP formulations are under development; however, their stability limitations necessitate frozen storage, posing a significant challenge for long-term storage and transportation.
Peng Gao +15 more
core +1 more source
Summary and Work Group interpretation : extended intervals for mRNA COVID-19 vaccines [PDF]
12-COVID-Oliver-508 ...
core
mRNA vaccine designs for optimal adjuvanticity and delivery
RNA BiologyAdjuvanticity and delivery are crucial facets of mRNA vaccine design. In modern mRNA vaccines, adjuvant functions are integrated into mRNA vaccine nanoparticles, allowing the co-delivery of antigen mRNA and adjuvants in a unified, all-in-one formulation.
Yuki Mochida, Satoshi Uchida
doaj +1 more source
Background: Respiratory syncytial virus (RSV) and varicella–zoster virus (VZV) pose significant risks to the elderly and individuals with compromised immune systems. In this study, we investigated whether combining RSV and VZV vaccines could reduce
Dandan Gao +8 more
core +1 more source
Unlocking translational resilience for mRNA vaccines by viral UTRs. [PDF]
Mol Ther Nucleic AcidsMinnell JJ, Vink JNA, McKenzie RE.
europepmc +1 more source
A protocol for computational design of mRNA vaccines with high functionality and specificity. [PDF]
Biol DirectRamadan MA +3 more
europepmc +1 more source
mRNA Vaccines in Melanoma Immunotherapy-A Narrative Review. [PDF]
CellsPlewa P +4 more
europepmc +1 more source
mRNA vaccines in oncology: personalized cancer immunization and neoantigen targeting. [PDF]
Mol Cell OncolParganiha M, Rathored J, Sai Painkra D.
europepmc +1 more source